Prostate Cancer Diagnosis

From the reviews: "This textbook, aimed to provide the reader with an exhaustive update, even if some points-of-view could be construed as controversial. ... The role of the pathologist was described in a very well-illustrated chapter that presents various pathological features, while the need of effective collaboration with clinicians was also underscored by the authors. ... Most urologists will find valuable information in this outstanding textbook, which is undoubtedly useful for their practice." (European Urology Today, June-July, 2013) "This book addresses the very timely issues of prostate cancer screening, diagnosis, and management of biopsy findings suspicious but short of a diagnosis of prostate cancer. ... This is a timely and outstanding review of complex and controversial issues pertaining to prostate cancer diagnosis. It is a terrific resource for clinicians, public health specialists, and lay people interested in obtaining a thorough understanding of these critical issues that affect so many men." (Mark Hurwitz, Doody's Book Reviews, March, 2013)

• Ch.1: Defining the Problem.- Ch.2: Prostate Cancer Screening: Navigating the Controversy.- Ch.3: Is the PSA Era Over?.- Ch.4: PSA Dynamics.- Ch.5: Percent Free PSA.- Ch.6: PCA3 and other Urinary Markers.- Ch.7: Blood-Based Tumor Markers for Prostate Cancer.- Ch.8: Prediction Models in Prostate Cancer Diagnosis and Preparation for Biopsy.- Ch.9: Is There a Role for Medications to Reduce the Need for Prostate Biopsy?.- Ch.10: Indications For Initial Biopsy:  Is The PSA Threshold Over?.- Ch.11: Preparation for Prostate Biopsy.- Ch.12: Pain Prevention.- Ch.13: Prostate Biopsy.- Ch.14: Prostate Biopsy Techniques.- Ch.15: Transperineal Biopsy.- Ch.16: Pathological Implications of Prostate Biopsy.- Ch.17: Complications of Transrectal Ultrasound Guided Prostate Biopsy.- Ch.18: After the Biopsy: Management of High Grade Prostatic Intraepithelial Neoplasia (HGPIN).- Ch.19: Atypical Small Acinar Proliferation.- Ch.20: Repeat Prostate Biopsy Strategies – Indications and Techniques.- Ch.21: Transperineal Mapping Biopsy of the Prostate for Assessment of the Minimal Risk Patient.- Ch.22: Management of the Patient Following a Negative Biopsy: Saturation Biopsy.- Ch.23: Role of imaging as an adjunct or replacement for biopsy: American Experience.- Ch.24: Role Of Imaging As An Adjunct Or Replacement For Biopsy: European Experience.- Ch.25: Prostate Cancer Detection: Lessons Learnt in the Cleveland Clinic Experience with Focus on the Negative Biopsy.- Ch.26: Future Directions in Prostate Cancer Diagnosis.